1.Stem cell researchImpaired function of bone marrow stromal cells in systemic mastocytosis.2015"12-1057 was used in Flow cytometry/Cell sorting to implicate epigenetic change in mesenchymal stem cells as a driver of some of the symptoms associated with systemic mastocytosis."Authors Nemeth K,Wilson TM,Ren JJ,Sabatino M,Stroncek DM,Krepuska M,Bai Y,Robey PG,Metcalfe DD,Mezey E2.NPJ Regenerative medicineCRISPR/Cas9-based genetic correction for recessive dystrophic epidermolysis bullosa.2018"12-1057 was used in Flow cytometry/Cell sorting to showcase the therapeutic potential of gene-editing coupled with stem cell technology for the treatment of recessive dystrophic epidermolysis bullosa."Authors Webber BR,Osborn MJ,McElroy AN,Twaroski K,Lonetree CL,DeFeo AP,Xia L,Eide C,Lees CJ,McElmurry RT,Riddle MJ,Kim CJ,Patel DD,Blazar BR,Tolar J3.Stem cell research and therapyHuman umbilical cord mesenchymal stem cells improve the reserve function of perimenopausal ovary via a paracrine mechanism.2017"12-1057 was used in Flow cytometry/Cell sorting to investigate the potential of hUCMSCs in improving ovarian function and withstanding ovarian senescence."Authors Li J,Mao Q,He J,She H,Zhang Z,Yin C4.Stem cell research and therapyHuman umbilical cord mesenchymal stem cells improve the reserve function of perimenopausal ovary via a paracrine mechanism.2017"12-1057 was used in Flow cytometry/Cell sorting to investigate the potential of hUCMSCs in improving ovarian function and withstanding ovarian senescence."Authors Li J,Mao Q,He J,She H,Zhang Z,Yin C5.Scientific reportsPotency of umbilical cord blood- and Wharton's jelly-derived mesenchymal stem cells for scarless wound healing.2016"12-1057 was used in Flow cytometry/Cell sorting to determine that umbilical cord blood offers a potential source of MSCs for therapeutic scarless wound healing."Authors Doi H,Kitajima Y,Luo L,Yan C,Tateishi S,Ono Y,Urata Y,Goto S,Mori R,Masuzaki H,Shimokawa I,Hirano A,Li TS |